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Background: Surgical site infection (SSI) is a potentially morbid and costly complication of surgery. While gastrointestinal surgery is 
relatively common in Korea, few studies have evaluated SSI in the context of gastric surgery. Thus, we performed a prospective cohort 
study to determine the incidence and risk factors of SSI in Korean patients undergoing gastric surgery. 
Materials and Methods: A prospective cohort study of 2,091 patients who underwent gastric surgery was performed in 10 hospitals 
with more than 500 beds (nine tertiary hospitals and one secondary hospital). Patients were recruited from an SSI surveillance pro-
gram between June 1, 2010, and August 31, 2011 and followed up for 1 month after the operation. The criteria used to define SSI 
and a patient’s risk index category were established according to the Centers for Disease Control and Prevention and the National 
Nosocomial Infection Surveillance System. We collected demographic data and potential perioperative risk factors including type 
and duration of the operation and physical status score in patients who developed SSIs based on a previous study protocol.
Results: A total of 71 SSIs (3.3%) were identified, with hospital rates varying from 0.0 - 15.7%. The results of multivariate analyses 
indicated that prolonged operation time (P = 0.002), use of a razor for preoperative hair removal (P = 0.010), and absence of laminar 
flow in the operating room (P = 0.024) were independent risk factors for SSI after gastric surgery.
Conclusions: Longer operation times, razor use, and absence of laminar flow in operating rooms were independently associated 
with significant increased SSI risk after gastric surgery.
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Introduction
Surgical site infection (SSI) is the most common type of 
healthcare-associated infection in patients undergoing sur-
gery and remains a major source of postoperative morbidity 
[1] Among surgical patients, SSIs account for 38% of health-
care-associated infections [2]. Of 16 million patients undergo-
ing surgical procedures in the United States each year, it is es-
timated 2 to 5% developed SSIs [3, 4]. SSIs can lead to 
prolonged hospitalization, increased morbidity and mortality, 
and increased surgery-related costs [5, 6]. Therefore, to reduce 
SSIs, it is important to clarify risk factors.
 The National Nosocomial Infection Surveillance (NNIS) risk 
indices for SSIs comprise three crucial measures, namely, the 
American Society of Anesthesiologists (ASA) classification, 
wound classification, and operation duration [7-9]. SSI rates 
correlate with the magnitude of the risk index in 77% (34/44) 
of NNIS procedure categories [8]. In Korea, the incidence of 
SSI ranges from 2.0% to 9.7% based on previous studies of var-
ious surgical procedures including gastrointestinal, hepatobil-
iary, orthopedic, gynecologic, and cardiac surgery [10-13].
Risk factors for SSIs have been well studied in various types 
of gastrointestinal surgery, particularly colorectal surgery [14-
16]; however, little information is currently available on risk 
factors for SSIs after gastrectomy. Gastrointestinal surgery is 
relatively common in Korea, especially for treatment of gastric 
cancer. Indeed, according to the 2007 National Survey in Ko-
rea, gastric cancer incidence rate in men and women reached 
62.8 and 25.7 cases per 100,000 people, respectively [17]. For 
these reasons, we investigated the incidence rate and charac-
teristics of SSI after gastric surgery. 
Materials and Methods
1. Patients and study design
Data were obtained from 10 hospitals in various regions 
around Korea. Each participating hospital comprised more 
than 500 beds, and nine were university-affiliated teaching 
hospitals. All patients who underwent gastric surgery from 
June 1, 2010 to August 31, 2011 at the Korean hospitals evalu-
ated in this study were prospectively enrolled. Patients with 
the following criteria were excluded from the evaluation co-
hort: (1) preoperative identification of infectious disease; (2) 
febrile status within 24 hours prior to surgery; (3) an ASA 
score ≥ 4; (4) transfer to another hospital during the follow-up 
period for which data were not collected; (5) emergent sur-
gery; (6) surgery for trauma; (7) more than two surgeries dur-
ing the same hospital stay; and (8) multiple surgical sites dur-
ing the same operation.
2. Data collection
The duration of the follow-up period used to identify SSIs 
was the first 30 days post-operation. Data were collected for 
the surgical procedure performed and potential SSI risk fac-
tors. Data from patients who developed SSIs were collected as 
previously described [7, 18-21], and these data included de-
mographic characteristics, dates of admission and discharge, 
presence of anemia (hemoglobin level < 10 mg/dL) during 
preoperative evaluation, steroid use (at least 6 weeks) within 6 
months of surgery, use of immunosuppressive drugs other 
than steroids within one month of surgery, history of chemo-
therapy within one month of surgery, current use of antacid 
medication within one week of surgery, hemoglobin A1c lev-
els for 3 months prior to surgery, operation characteristics 
(i.e., type, date, and duration of the surgical procedure, ASA 
physical status score [22], and any use of endoscopic surgical 
approach), total amount of blood loss during the operation, 
preoperative hair removal methods, perioperative antimicro-
bial prophylaxis, presence of drains, occurrence of SSI, the en-
vironment of operating rooms, and microbiological data for 
any SSIs that developed.
3. Definitions 
The criteria used to define SSIs and a patient’s risk index cat-
egory were established according to the guidelines of the CDC 
and NNIS [2, 4, 7, 23, 24]. The NNIS risk index score for each 
patient was calculated by assigning one point for each con-
taminated wound according to the CDC definition [25], an 
ASA score ≥ 3, and surgical procedures lasting longer than the 
NNIS-derived 75th percentile for procedure duration (T time). 
The NNIS score was modified by subtracting 1 point for cases 
where the surgery was performed by a laparoscopic approach 
as suggested by Gaynes et al.[8]. A SSI group was defined as 
patients who underwent gastric surgery during the study peri-
od at any of the participating hospitals and who acquired an 
SSI according to the CDC criteria. 
Antimicrobial prophylaxis was considered optimal if a first- 
or second- generation cephalosporin was administered intra-
venously within the 60 min period preceding incision in the 
absence of a β-lactam allergy, and if prophylactic antimicrobi-
als were discontinued within 24 h after the surgery was com-
pleted [26].
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4. Statistical analysis
All factors were compared between the SSI group and non-
SSI group using Student’s t-test or Chi-square  test. Relation-
ships between dichotomous variables were assessed using 
Pearson’s Chi-square  test. Multivariate analysis was also per-
formed using a logistic regression model and stepwise regres-
sion to assess the effects of various factors on SSIs. All statisti-
cal tests were performed using SPSS software for Windows, 
version 18.0 (SPSS Inc., Chicago, IL, USA). All P-values were 
two-tailed, and values less than 0.05 were considered statisti-
cally significant.
Results
 From June 2010 to August 2011, a total of 2,091 patients 
who underwent gastric surgery were included in the study. 
SSIs were noted in 71 of 2,091 (3.3%) patients following gastric 
surgery, with varying from 0.0% to 15.7% according to each 
hospital. The clinical characteristics and preoperative status of 
study participants are summarized in Table 1. There were no 
significant differences in age and gender between the SSI and 
non-SSI groups (P = 0.290 and 0.312, respectively). Univariate 
analysis did not find an association between underlying dis-
eases and SSI development in the two groups. Patients with a 
history of chemotherapy within 1 month of the surgery were 
noted more frequently in the SSI group compared with the 
non-SSI group (5.6% vs. 0.8%; P < 0.001). In addition, patients 
with an SSI had a longer median duration of hospital stay 
(18.5 [14.0-25.0] vs. 10.0 [9.0-13.0] days, P < 0.001). The associ-
ation between methods of surgery-related variables and SSIs 
are presented in Table 2. Patients with early gastric cancer 
Table 1.  Baseline characteristics and preoperative status of study patients
SSI group
N = 71 
Non-SSI group
N = 2,020 
P-value
Age, years (mean ± SD) 60.1 ± 13.2 58.5 ± 12.4 0.290a
Gender, male (range)   51 (71.8) 1,274 (63.1) 0.312
BMI , kg/m2         23.9 (21.9-25.8)           23.1 (21.1-25.4) 0.137b
Comorbidity
 DM 12 (16.9) 284 (14.1) 0.518
 Solid Cancer 4 (5.6) 357 (17.7) 0.060
 Hematologic malignancy 0 (0.0)   4 (0.2) 1.000
 Cardiovascular disease 28 (4.4) 610 (30.2) 0.111
 SOT 0 (0.0)   5 (0.2) > 0.999
 Lung disease 2 (2.8) 45 (2.2) 0.763
 Renal disease 0 (0.0) 10 (0.5) 0.378
 Liver disease 2 (2.8) 62 (3.1) 0.548
Smoking history, yes 20 (28.2) 502 (24.9) 0.534
Total duration of HS, days (range)        18.5 (14.0-25.0)       10.0 (9.0-13.0) < 0.001 b
Type of discharge 0.016c
  Discharge after recovery 69 (97.2) 2,016 (99.8)
  In hospital mortality 2 (2.8)   4 (0.2)
Anemia (Hb <10 mg/dL) 4 (5.6) 70 (3.5) 0.315
Immunosuppressant use
  Steroid 0 (0.0)   8 (0.4) 0.573
  Others 0 (0.0)   3 (0.1) > 0.999
Chemotherapy, yes 4 (5.6) 17 (0.8) < 0.001
Antacid medication history, yes 16 (22.5) 540 (26.7) 0.417
HbA1c (mean ± SD) 6.37 ± 0.83 6.87 ± 1.33 0.102 a
SD, standard deviation; BMI, body mass index; DM, diabetes mellitus; SOT, solid organ transplantation; HS, hospital stay; Hb, hemoglobin; SSI, surgical site infection.
Data are expressed as the mean ± SD, number (percent), or median (interquartile range).
aStudent’s t -test. 
bMann-Whitney U test.
cFisher’s Exact Test.
  http://dx.doi.org/10.3947/ic.2013.45.4.422  •  Infect Chemother 2013;45(4):422-430www.icjournal.org 425
were observed more frequently in the non-SSI group (33.8% 
vs. 49.4%; P = 0.010). Surgery to treat advanced gastric cancer 
was more common in the SSI group compared with the non-
SSI group (62.0% vs. 45.3%; P = 0.005).  A higher percentage of 
patients underwent total gastrectomy (TG) with and without 
lymph node (LN) dissection in the SSI group than the non-SSI 
group (26.8% vs. 12.9%; P = 0.001 and 18.3% vs. 10.8%; P = 
0.049, respectively).
Univariate analysis of perioperative and postoperative risk 
factors showed that patients in the SSI group had longer dura-
tions of surgery (P < 0.001) compared to the non-SSI group, as 
well as longer durations of surgical drainage (P = 0.002) (Table 
3). Further, the SSI group had a significantly higher percent-
age of razor use for preoperative hair removal (52.1% vs. 
18.2%, P < 0.001) and no surgical drainage was performed in 
fewer patients in the SSI group than the non-SSI group (9.9% 
vs. 29.7%, P < 0.001) (Table 3).
Based on our evaluation of operating room environments, 
SSI risk increased when surgeries were performed in the ab-
sence of laminar air-flow (36.6% vs. 7.2%, P < 0.001). There 
were no significant differences between SSI and non-SSI 
groups among any other operating rooms factors, including 
high-efficiency particulate air filters, time for complete air ex-
change, maintenance of positive pressure, and use of instru-
ments for temperature measurement.
Pathogens associated with SSIs were identified in 56 of 71 
patients. A total of 68 microbial species were isolated: 29 
Gram-positive, 25 Gram-negative, and 14 other species. The 
Gram-positive species consisted of methicillin-resistant coag-
ulase negative staphylococci (n = 7), methicillin-resistant 
Staphylococcus aureus (n = 7), Enterococcus faecalis (n = 7), 
Enterococcus faecium (n = 4), methicillin-sensitive Staphylo-
Table 2. Association between selected variables and surgical site infection following gastric surgery
SSI group
N = 71
Non-SSI group
N  = 2,020
P-value
Reasons for gastric surgery
Early gastric cancer 24 (33.8) 998 (49.4) 0.010a
Advanced gastric cancer 44 (62.0) 914 (45.3) 0.005 a
Other gastric malignancy 1 (1.4) 84 (4.2) NS
Benign gastric tumor 2 (2.8) 14 (0.7) NS
Benign GU without intractable bleeding 0 (0.0)   5 (0.2) NS
Malignancy of other primary site except stomach 0 (0.0)   2 (0.1) NS
Benign GU with intractable bleeding 0 (0.0)   1 (0.0) NS
Otherb 0 (0.0)   2 (0.1)  NS
Type of operation
TG with LN dissection 19 (26.8) 260 (12.9) 0.001 a
TG without LN dissection 13 (18.3) 219 (10.8) 0.049 a
TG, thoracic and abdominal approach with LN dissection 2 (2.8) 14 (0.7) 0.100c
PG with LN dissection 14 (19.7) 470 (23.3) NS
PG without LN dissection   9 (12.7) 575 (28.5) 0.004 a
DG with LN dissection   8 (11.3) 204 (10.1) NS
DG without LN dissection 5 (7.0) 138 (6.8) NS
Pylorus preserving STG with LN dissection 0 (0.0) 24 (1.2) NS
Pylorus preserving STG 1 (1.4) 17 (0.8) NS
Wedge resection of stomach with LN dissection 0 (0.0)   5 (0.2) NS
Wedge resection of stomach 0 (0.0) 77 (3.8) NS
Proximal gastrectomy with LN dissection 0 (0.0)   6 (0.3) 1.000c
GU, gastric ulcer; TG, total gastrectomy; LN, lymph node; PG, partial gastrectomy; DG, distal gastrectomy; STG, subtotal gastrectomy; NS, not significant; SSI, surgical site 
infection.
aPearson Chi-square.
bGastric surgery due to obesity.
cFisher’s Exact Test.
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Table 3. Perioperative and postoperative risk factors of surgical site infection
SSI group
N = 71 (%)
Non-SSI group
N = 2,020 (%)
P-value
ASA scorea 0.968
1   47 (66.2) 1,268 (62.8)
2   17 (23.9)     664 (32.9)
3     7 (9.9)        88 (4.3)
NNIS risk score
ASA score  ≥ 3      7 (9.9)        88 (4.3) 0.083
Operation classified as either contaminated or dirty-infected, yes      0 (0.0)          9 (0.4) 0.925
Duration of operation > T time, yes   56 (78.9) 1,022 (50.6) <0.001
Laparoscopic surgery   30 (42.3)    693 (34.3) 0.166
NNIS risk score ≥ 1  35 (49.3)    645 (31.9) 0.002b
Total duration of OP, min  (mean ± SD) 255 ± 104   190 ± 72 <0.001c
Total amount of blood loss during OP, mL (range) 125 (50-600)    150 (74-306) 0.196 b
Preoperative hair-removal methods
Razor   37 (52.1)    368 (18.2) <0.001
Electric clipper   30 (42.3) 1,164 (57.6) 0.010
No shaving     4 (5.6)    249 (12.3) NS
Unknown     0 (0.0)    239 (11.8) NS
Surgical drainage, yes
No use of drain     7 (9.9)    600 (29.7) <0.001
Closed, suction   35 (39.4)    899 (44.5) 0.398.
Closed, non-suction   36 (50.7)    520 (25.7) NS
Open     0 (0.0)         1 (0.0) NS
Total duration of surgical drain, days (range) 8.5 (5.0-13.0)     6.0 (5.0-8.0) 0.002 b
Prophylactic antibiotics use
Administration within 1h of the start of surgery  (mean ± SD) 0.906
Yes   69 (97.2) 1,927 (95.4)
No     2 (2.8)       78 (3.9)
Unknown     0 (0.0)       15 (0.7)
Total duration of prophylactic antibiotics use, parenteral, days     4 (2-5)         4 (2-5) 0.056 b
Optimal antibiotic prophylaxis, yes   31 (43.7)    912 (45.1) 0.805
The environment of operating rooms
Laminar flow, yes   45 (63.4) 1,874 (92.8) <0.001
HEPA filter, yes   66 (93.0) 1,897 (93.9) 0.961
Air change > 15 times/hours, yes   66 (93.0) 1,913 (94.7) NS
Maintenance of positive pressure, yes   69 (97.2) 2,001 (99.1) NS
Instrument for temperature measurement, yes   69 (97.2) 2,012 (99.6) NS
ASA, American Society of Anesthesiology; NNIS, National Nosocomial Infection Surveillance; OP, operation; HEPA, high-efficiency particulate air; NS, not significant; SD, 
standard deviation; SSI, surgical site infection.
Data are expressed as the mean ± SD or number (percent) or median (interquartile range).
ahealthy, 1; mild systemic disorder, 2; severe systemic disorder, ≥ 3.
bMann-Whitney U test.
cStudent’s t -test. 
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coccus aureus (n = 3), and methicillin-sensitive coagulase-
negative staphylococci (n = 1). The Gram-negative species 
consisted of Enterobacter cloacae (n = 11), Klebsiella pneu-
monia (n = 5), Escherichia coli (n = 4), Acinetobacter bau-
mannii (n = 3), and Pseudomonas aeruginosa (n = 2).
Table 4 shows multivariate adjusted odds ratios for SSIs after 
gastric surgery. Independent risk factors for SSIs after gastric 
surgery were prolonged operation time (P = 0.002), use of a 
razor for preoperative hair-removal (P = 0.010), and absence 
of laminar flow in the operating room (P = 0.024).
Discussion
We performed a prospective cohort study to identify risk 
factors for SSI after gastric surgery. We found that prolonged 
surgery time, use of a razor for preoperative hair removal, and 
absence of laminar flow in the operating room were indepen-
dent risk factors for SSI following gastric surgery. Gastrointes-
tinal surgery is relatively common in Korea, especially to treat 
gastric cancer. The 2007 National Survey in Korea, reported 
the incidence of gastric cancer in men and women to be 62.8 
and 25.7 cases per 100,000 people, respectively [17]. There-
fore, the results of this study on SSI incidence in patients un-
dergoing gastric surgery may be especially meaningful.
The rates of SSI for individual procedures vary widely de-
pending on numerous factors, including population, hospital 
size, surgeon experience, and post-surgery surveillance meth-
ods. In addition, nonteaching hospitals generally have lower 
SSI rates than teaching hospitals [27]. Several studies have 
noted an increased risk of SSI in patients with cancer who un-
dergo surgical procedures [28]. Previous studies have reported 
rate and risk factors for SSIs after gastric surgery in Korea. Kim 
et al. [29] evaluated a total of 499 cases for SSI between July 
and December 2007 in 5 teaching hospitals with more than 
500 beds. They found an SSI rate of 4.4% (22/499), and report-
ed that diabetes mellitus, reoperation, emergent operation, 
and transfusion were more frequent in the infected group. 
Likewise, another prospective study monitored 4,238 patients 
across 20 Korean hospitals between 2007 and 2009 for SSIs for 
30 days after gastric surgery [30], and reported an SSI rate of 
4.0% (170/4,068) with Staphylococcus aureus and Klebsiella 
pneumonia as most frequently isolated microorganisms. In 
addition, male gender, reoperation, combined multiple proce-
dures, prophylactic administration of the first antibiotic dose 
after skin incision, and prolonged administration (≥7 days) of 
prophylactic antibiotics were all independently associated 
with increased risk of SSI. Another study monitored a total of 
3,286 cases from 23 hospitals in Korea between July 2010 and 
June 2011 (1 hospital with < 500 beds, 12 hospitals with 700-
899 beds, and 10 hospitals with > 900 beds) [31]. In that study, 
the SSI rate after gastric surgery was 3.5% (115/3,286), and en-
terococci (n = 19) was the most frequently detected pathogen. 
In the present study, we observed an SSI rate of 3.3% (71/2,091); 
staphylococci (n = 14) and enterococci (n = 11) were most fre-
quently isolated. We observed a lower SSI rate after gastric 
surgery than that found in previous reports; various methods 
for monitoring nosocomial infections may have contributed 
to this improved rate.
 In our study, using both univariate and multivariate regres-
sion analyses, we confirmed that prolonged operation time is 
a risk factor for SSI after gastric surgery. Our findings were 
similar to previously reported NNIS data, which included the 
75th percentile of operation duration after initial cut point (3 
hours)[32, 33].
 We found that preoperative hair removal with a razor was a 
significant and independent risk factor for SSI after gastric 
surgery. Shaving with a razor before surgery is a well-docu-
mented risk factor for SSI, and guidelines from the CDC 
Healthcare Infection Control Practices Advisory Committee 
(HICPAC) recommend avoidance of hair removal before sur-
gery when possible and the use of clippers if hair removal is 
necessary [2]. Despite these guidelines, we were surprised to 
find that 19.4% (405/2,091) of study patients were shaved with 
a razor before gastric surgery. Thus, avoiding razor shaving 
before surgery is a modifiable intervention to reduce the risk 
of SSIs.
 Laminar airflow ventilation systems in operating rooms are 
frequently recommended for to prevent SSIs. However, for all 
other types of surgery, there is no evidence from controlled 
Table 4. Multivariate analysis of SSI risk factors
Odds ratio 95% CI P-value
Use of a razor for preoperative hair removal 2.49 1.25 to 5.01 0.010
Duration of operation > T time 2.59 1.40 to 4.79 0.002
Absence of laminar flow in operating room 2.45 1.13 to 5.31 0.024
CI, confidence interval; SSI, surgical site infection.
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clinical trials that clean air conditions are beneficial for the 
prevention of post-surgical infections. HICPAC guidelines for 
the prevention of SSIs [2], published in 1999, recommended 
to “consider performing orthopedic implant operations in op-
erating rooms supplied with ultraclean air” which was classi-
fied as a category II recommendation. Since then, no further 
evidence from controlled trials has supported the need for 
clean air conditions. Consequently, the 2003 HICPAC guide-
lines for environmental infection control [34] do not recom-
mend  recommendation on performing orthopedic implant 
surgery in rooms supplied with laminar airflow. In 2011, two 
additional large cohort studies investigated the effects of lami-
nar airflow on SSI rates following orthopedic surgery [35, 36]. 
Neither study found that SSI rates were lower in patients 
whose operations were performed under laminar airflow con-
ditions in one study, the opposite was found [35]. On the other 
hand, some studies have shown that laminar airflow systems 
reduce bacterial burden in operating room air [37], especially 
when comparing old and new operating rooms [38]. However, 
there has been no correlation established between airborne 
bacteria counts and SSI rates. 
In this study, absence of laminar airflow in operating room 
increased the risk of SSIs by 2.45 fold according to the results 
of multivariate analysis. Although the benefits of laminar air-
flow for preventing SSIs is a matter of debate and implemen-
tation and continued operation of laminar airflow technology 
is costly compared with conventional ventilation systems, the 
results of our study provide strong evidence to support the 
benefits of laminar airflow in operating rooms. 
Perioperative antimicrobial prophylaxis is intended to elimi-
nate most of the pathogens brought into wounds shortly be-
fore and/or during surgical procedures and therefore decrease 
the risk of subsequent SSIs. Gram-positive bacteria should be 
covered by selected antibiotics for this purpose [39], and 
timely administration is crucial in order to achieve the highest 
local concentration of the chosen antibiotic regimen at the 
beginning time of surgery [40]. However, there were no signifi-
cant differences between the SSI and non-SSI groups accord-
ing to optimal antibiotic prophylaxis in our study. Although 
this lack of benefit from antimicrobial prophylaxis was unex-
pected, several other studies have reported similar observa-
tions [41, 42]. The effectiveness of prophylactic antibiotics var-
ies among types of gastrointestinal surgery. A meta-analysis of 
laparoscopic cholecystectomies showed that prophylactic an-
tibiotics are ineffective in preventing postsurgical complica-
tions, while antibiotic prophylaxis was shown to reduce SSIs 
in colectomies and appendectomies [26, 43, 44]. In colon sur-
gery, randomized clinical trials to evaluate prophylactic anti-
biotics were conducted in the 1980s, and placebo groups had 
SSI rates of approximately 40%, nearly twice the rate of our 
corresponding group [26]. Although not all of our results are 
generalizable, improvement of other pre- and intraoperative 
patient management such as avoiding preoperative shaving 
and prevention of hypothermia may contribute to reduced 
risks. In addition, the overall reduction of SSI rates in colecto-
mies may make it difficult to determine the effectiveness of 
prophylactic antibiotic.
One limitation of this study was that the NNIS was not pre-
dictive for SSI occurrence. In addition, we did not evaluate 
risk factors of SSI in patients with colon surgery; therefore, we 
could not directly compare differences between risk factors 
for gastric and colon surgeries.
In conclusion, SSI risk after gastric surgery was mainly asso-
ciated with prolonged surgeries, use of razors for preoperative 
hair removal, and absence of laminar flow in operating rooms. 
These factors are potentially modifiable, and we believe that 
these results will be helpful in lowering SSI rates after gastric 
surgery in Korea.
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